Imunon, Inc. (IMNN)
2.92
-0.14
(-4.58%)
USD |
NASDAQ |
Apr 10, 16:00
2.98
+0.06
(+2.05%)
After-Hours: 20:00
Imunon Shareholders Equity (Quarterly) : 7.062M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Corcept Therapeutics, Inc. | 647.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.29M |
| Total Liabilities (Quarterly) | 5.226M |
| Debt to Equity Ratio | 0.1429 |
| Current Ratio | 2.319 |
| Net Debt Paydown Yield | 0.64% |